Slimonil
$ 53,00 – $ 76,00Price range: $ 53,00 through $ 76,00
Solian
$ 89,00 – $ 745,00Price range: $ 89,00 through $ 745,00
Snovitra
$ 41,00 – $ 327,00Price range: $ 41,00 through $ 327,00
Snovitra is an effective medication specifically designed to help men manage the symptoms of erectile dysfunction. The active ingredient, Vardenafil, works by increasing blood flow to specific areas of the body to support a firm and lasting response. This fast-acting formula provides reliable results, allowing for greater confidence and improved performance during intimate moments. Manufactured to high standards, it ensures consistent quality for those seeking a dependable solution to enhance their sexual health. Snovitra offers a discreet and practical way to regain control and enjoy a more fulfilling personal life.
Active substance: Vardenafil
SKU:
Snovitra
Category: Erectile Dysfunction
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Snovitra – Information for Patients and Caregivers
Snovitra belongs to the class of medications known as phosphodiesterase type 5 (PDE5) inhibitors, which are utilized to support vascular smooth muscle relaxation. It is primarily evaluated for the management of erectile dysfunction by enhancing local arterial blood flow response during sexual stimulation. In the United States, medications within this pharmacological class are dispensed in accordance with applicable federal and state regulations under professional medical supervision.
Understanding the physiological mechanics, potential interactions, and risk profile of Snovitra helps ensure informed clinical decision-making alongside a qualified healthcare provider. While PDE5 inhibitors share common therapeutic principles, individual treatment outcomes and tolerability profiles can vary based on underlying health conditions.
| Attribute | Details |
|---|---|
| Active Ingredient (INN) | Vardenafil |
| Therapeutic Class | PDE5 Inhibitor |
| Route of Administration | Oral |
| Primary Purpose | Erectile Dysfunction |
| Prescription Status | Dispensed in accordance with applicable federal and state regulations |
| Storage | Store at controlled room temperature away from moisture |
How the drug works
The active constituent in Snovitra acts by selectively inhibiting the cGMP-specific phosphodiesterase type 5 enzyme. Under normal physiological conditions, sexual arousal triggers the localized release of nitric oxide from nerve endings and endothelial cells in the corpus cavernosum. Nitric oxide then stimulates the enzyme guanylate cyclase, leading to increased intracellular concentration of cyclic guanosine monophosphate (cGMP). Elevated cGMP promotes vascular smooth muscle relaxation, allowing increased blood flow into penile tissues to facilitate an erection.
By preventing the enzymatic degradation of cGMP by PDE5, Snovitra helps maintain adequate local cGMP levels during periods of sexual stimulation. On one hand, this targeted action offers a localized vascular benefit without directly initiating an erection in the absence of sensory or mental arousal. On the other hand, because PDE5 enzymes exist in minor concentrations within systemic vascular beds, mild arterial vasodilation can occur throughout the body, accounting for both its primary therapeutic effects and potential systemic side effects.
Main uses
Snovitra is indicated for the treatment of erectile dysfunction (ED), a condition characterized by the persistent inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. While age-related vascular changes frequently contribute to ED, underlying conditions such as diabetes mellitus, hypertension, dyslipidemia, and psychogenic factors also play prominent roles in its etiology.
It is crucial to recognize that PDE5 inhibitors do not cure the underlying organic causes of erectile dysfunction, nor do they act as sexual stimulants or aphrodisiacs. Any potential off-label applications of PDE5 inhibitors–such as off-label use for specific secondary symptoms of Raynaud’s phenomenon–must be explicitly designated and monitored by a licensed prescriber, as formal regulatory approvals remain focused on established vascular indications.
How to take it
Specific dosing regimens for Snovitra are determined individually by a healthcare provider based on clinical response, individual tolerance, and concurrent medical conditions. Generally, oral administration occurs approximately 25 to 60 minutes prior to anticipated sexual activity. The tablet should be swallowed whole with water, and no more than one dose should be administered within a single 24-hour window.
Dose modifications may be required for specific clinical populations. For example, individuals with mild-to-moderate hepatic impairment or severe renal insufficiency often require lower initial starting doses. Patients must not alter their assigned dosing schedule or increase consumption frequency without clinical consultation, as higher doses do not enhance therapeutic efficacy and significantly increase the risk of adverse reactions.
How it’s absorbed and eliminated
Following oral administration, the active drug Vardenafil is rapidly absorbed from the gastrointestinal tract, reaching peak plasma concentration within approximately 30 to 120 minutes under fasting conditions. The absolute oral bioavailability is estimated at approximately 15%, predominantly due to substantial first-pass hepatic metabolism. Plasma protein binding is extensive, reaching approximately 95% bound to circulating serum proteins.
Biotransformation occurs primarily in the liver via cytochrome P450 enzymes, specifically the CYP3A4 isoform, with secondary contributions from CYP3A5 and CYP2C pathways. The major circulating metabolite undergoes further systemic elimination and demonstrates partial pharmacological activity. Excretion takes place mainly via the fecal route (approximately 79% to 91% of the administered dose), with a smaller portion eliminated through renal excretion (around 2% to 13%). The terminal elimination half-life generally ranges from 4 to 5 hours in healthy adults.
What not to combine
Combining Snovitra with organic nitrates (such as nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate) or nitric oxide donors is strictly contraindicated. Co-administration can trigger a sudden, severe, and potentially dangerous drop in systemic blood pressure due to cumulative vasodilatory effects. Similarly, concurrent administration with soluble guanylate cyclase stimulators (such as riociguat) poses significant hypotensive risks.
Caution is mandatory when co-administering PDE5 inhibitors with alpha-blockers prescribed for hypertension or benign prostatic hyperplasia, as simultaneous use can lead to symptomatic orthostatic hypotension or syncope. Potent CYP3A4 inhibitors (including ketoconazole, itraconazole, ritonavir, and erythromycin) substantially increase systemic drug exposure, requiring lower starting doses or complete avoidance. Conversely, strong CYP3A4 inducers (such as rifampin) can reduce plasma levels, diminishing overall efficacy.
What to avoid while taking it
Dietary habits can influence the absorption speed of Snovitra. Ingesting high-fat meals shortly before taking the medication may delay gastric emptying and prolong the time required to achieve peak plasma concentration. While standard light meals do not typically alter effectiveness, heavy or high-fat foods can lead to a delayed onset of action.
Ethanol intake requires careful consideration. Although small amounts of alcohol may not interact directly, excessive alcohol consumption combined with PDE5 inhibitors can enhance peripheral vasodilation, increasing the incidence of orthostatic dizziness, headache, and tachycardia. Furthermore, grapefruit juice should be avoided because it inhibits intestinal CYP3A4 metabolism, leading to unpredictable increases in systemic drug absorption.
Adverse reactions
The side effect profile of Snovitra directly reflects its vasodilatory pharmacological properties. Most reported adverse events are mild to moderate in severity and self-limiting. Commonly reported adverse reactions include headache, cutaneous flushing, nasal congestion, dyspepsia (indigestion), and occasional lightheadedness. Some individuals may experience transient visual changes, such as mild color tinge or heightened light sensitivity.
Less common but more significant adverse reactions include back pain, myalgia, pronounced hypotension, and sudden changes in visual or auditory perception. Post-marketing surveillance of PDE5 inhibitors has recorded rare instances of non-arteritic anterior ischemic optic neuropathy (NAION), primarily in patients with pre-existing vascular risk factors. Any persistent or severe side effects should be evaluated by a healthcare professional.
Red flags
Although common side effects are usually transient, certain severe symptoms require immediate emergency medical evaluation. Prolonged erections lasting longer than 4 hours (priapism) demand prompt medical intervention to prevent permanent damage to erectile tissue. A sudden decline or complete loss of vision in one or both eyes, as well as a sudden decrease or loss of hearing accompanied by tinnitus, constitutes a medical emergency.
Immediate emergency care is also required if patients experience signs of a severe hypersensitivity reaction–such as swelling of the face, lips, tongue, or throat, or acute breathing difficulty–or cardiovascular red flags, including severe chest pain, extreme dizziness, or irregular cardiac rhythm during or after sexual activity.
| Symptom / Red Flag | Required Emergency Action |
|---|---|
| Erection lasting longer than 4 hours (priapism) | Seek emergency medical care immediately |
| Chest pain or severe shortness of breath | Discontinue activity and contact emergency services |
| Sudden loss of vision or hearing | Obtain immediate emergency medical evaluation |
| Swelling of face, lips, tongue, or throat | Seek urgent emergency allergy care |
Important precautions
Prior to starting treatment with Snovitra, a comprehensive medical history and physical evaluation are recommended to assess cardiovascular status. Because sexual activity involves a baseline level of cardiac exertion, clinicians must confirm whether a patient’s heart health can tolerate the physical strain. The medication should be used with extreme caution in patients with a history of recent myocardial infarction, stroke, resting hypotension, uncontrolled hypertension, unstable angina, or severe heart failure.
Special patient groups require tailored assessment. Elderly individuals may clear the medication more slowly, necessitating conservative initial dosing. The safety and efficacy of this drug have not been established in pediatric populations. Patients with structural penile deformities (such as Peyronie’s disease) or conditions predisposing them to priapism (such as sickle cell anemia, multiple myeloma, or leukemia) require strict clinical supervision.
If you skip a dose
Because Snovitra is generally intended for on-demand use prior to anticipated sexual activity, standard fixed daily schedules are rarely utilized. Missing an intended dose simply means the medication was not taken before activity. In such cases, the tablet may be taken when remembered, provided sufficient time is allowed before intimacy and the strict rule of one dose per 24 hours is maintained.
If a doctor has prescribed a specific scheduled regimen, patients should never double the dose to make up for a missed tablet. Taking extra doses increases the risk of severe blood pressure drops and adverse reactions without offering additional therapeutic benefits.
Practical tips
Incorporating Snovitra safely into a personal routine involves planning around timing and dietary factors. Scheduling administration approximately 30 to 60 minutes before planned intimacy allows adequate time for systemic absorption. Avoiding heavy, greasy meals around the time of dosing helps maintain predictable onset, while limiting alcohol intake minimizes the chance of dizziness or headache.
Patients are encouraged to monitor their response during initial uses. Communicating regularly with a healthcare provider regarding treatment efficacy and any side effects helps determine whether dose adjustments or alternative treatment strategies are appropriate.
Common questions
How long does the therapeutic effect of Snovitra typically last?
reached peak activity, the window of PDE5 inhibition generally spans 4 to 5 hours based on the active constituent’s half-life. However, an erection occurs only when natural sexual stimulation takes place during this window.
Is facial flushing or head pressure a typical reaction?
Yes, facial flushing and mild headache are among the most frequently observed side effects. They occur because PDE5 inhibitors exert mild vasodilatory effects on vascular beds throughout the body. If symptoms persist or become severe, consult your doctor.
What steps should be taken if the expected effect is not achieved?
Do not increase the dosage independently. Therapeutic response can be influenced by timing, food intake, stress, and underlying vascular health. Discuss the outcome with your prescriber, who can evaluate whether a dosage adjustment or different treatment protocol is suitable.
Can Snovitra be taken alongside routine blood pressure medications?
While some antihypertensive drugs can be used under medical supervision, co-administering PDE5 inhibitors with certain blood pressure treatments–especially nitrates and alpha-blockers–can trigger severe hypotension. Always review your complete drug list with a physician.
Does food intake significantly alter the onset of action?
High-fat meals can delay gastrointestinal absorption, resulting in a slower onset of action. Taking the tablet with water or after a light meal generally ensures more consistent absorption kinetics.
In accordance with FDA guidelines and US federal standards:
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
10 mg ,20mg ,40mg |
|---|---|
| Package |
50 pills ,60 pills ,90 pills ,100 pills ,120 pills ,150 pills ,180 pills ,200 pills ,270 pills ,300 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Alprostadil
$ 450,00
Active substance: Alprostadil
More Details
This product has multiple variants. The options may be chosen on the product page
Avana
$ 112,00 – $ 419,00Price range: $ 112,00 through $ 419,00
Active substance: Avanafil
More Details
This product has multiple variants. The options may be chosen on the product page
Bottled Levitra
$ 158,00 – $ 347,00Price range: $ 158,00 through $ 347,00
Active substance: Vardenafil
More Details
This product has multiple variants. The options may be chosen on the product page
Caverta
$ 135,00 – $ 248,00Price range: $ 135,00 through $ 248,00
Active substance: Sildenafil
More Details
This product has multiple variants. The options may be chosen on the product page
Cenforce Soft
$ 44,00 – $ 324,00Price range: $ 44,00 through $ 324,00
Active substance: Sildenafil
More Details
This product has multiple variants. The options may be chosen on the product page
Cialis Black
$ 51,00 – $ 401,00Price range: $ 51,00 through $ 401,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
Cialis Daily
$ 43,00 – $ 285,00Price range: $ 43,00 through $ 285,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
Cialis Soft
$ 54,00 – $ 442,00Price range: $ 54,00 through $ 442,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
